WO2001019997A3 - BASB128 polypeptide and polynucleotide from moxarella catarrhalis - Google Patents

BASB128 polypeptide and polynucleotide from moxarella catarrhalis Download PDF

Info

Publication number
WO2001019997A3
WO2001019997A3 PCT/EP2000/009036 EP0009036W WO0119997A3 WO 2001019997 A3 WO2001019997 A3 WO 2001019997A3 EP 0009036 W EP0009036 W EP 0009036W WO 0119997 A3 WO0119997 A3 WO 0119997A3
Authority
WO
WIPO (PCT)
Prior art keywords
basb128
polynucleotide
polypeptide
moxarella catarrhalis
polypeptides
Prior art date
Application number
PCT/EP2000/009036
Other languages
French (fr)
Other versions
WO2001019997A2 (en
Inventor
Joelle Thonnard
Original Assignee
Joelle Thonnard
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joelle Thonnard, Smithkline Beecham Biolog filed Critical Joelle Thonnard
Priority to AU79041/00A priority Critical patent/AU7904100A/en
Priority to EP00969255A priority patent/EP1212427A2/en
Priority to CA002383292A priority patent/CA2383292A1/en
Publication of WO2001019997A2 publication Critical patent/WO2001019997A2/en
Publication of WO2001019997A3 publication Critical patent/WO2001019997A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides BASB128 polypeptides and polynucleotides encoding BASB128 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2000/009036 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide from moxarella catarrhalis WO2001019997A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU79041/00A AU7904100A (en) 1999-09-14 2000-09-14 Novel compounds
EP00969255A EP1212427A2 (en) 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide fron moraxella catarrhalis
CA002383292A CA2383292A1 (en) 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide from moxarella catarrhalis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921692.1A GB9921692D0 (en) 1999-09-14 1999-09-14 Novel compounds
GB9921692.1 1999-09-14

Publications (2)

Publication Number Publication Date
WO2001019997A2 WO2001019997A2 (en) 2001-03-22
WO2001019997A3 true WO2001019997A3 (en) 2001-08-02

Family

ID=10860879

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009036 WO2001019997A2 (en) 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide from moxarella catarrhalis

Country Status (5)

Country Link
EP (1) EP1212427A2 (en)
AU (1) AU7904100A (en)
CA (1) CA2383292A1 (en)
GB (1) GB9921692D0 (en)
WO (1) WO2001019997A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997013785A1 (en) * 1995-10-11 1997-04-17 Connaught Laboratories Limited Transferrin receptor protein of moraxella
US5725862A (en) * 1993-09-29 1998-03-10 Research Foundation Of State University Of New York Vaccine for branhamelia catarrhalis
WO2000078968A2 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725862A (en) * 1993-09-29 1998-03-10 Research Foundation Of State University Of New York Vaccine for branhamelia catarrhalis
WO1997013785A1 (en) * 1995-10-11 1997-04-17 Connaught Laboratories Limited Transferrin receptor protein of moraxella
WO2000078968A2 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 4 June 1998 (1998-06-04), YONEYAMA ET AL: "Pseudomonas aeruginosa gene for OprM, complete cds.", XP002161345 *
MURPHY ET AL: "Studies of the outer membrane proteins of Branhamella catarrhalis", AMERICAN JOURNAL OF MEDICINE, vol. 88, no. SUPPL. 05A, 14 May 1990 (1990-05-14), pages 41S - 45S, XP002079419, ISSN: 0002-9343 *

Also Published As

Publication number Publication date
EP1212427A2 (en) 2002-06-12
GB9921692D0 (en) 1999-11-17
AU7904100A (en) 2001-04-17
WO2001019997A2 (en) 2001-03-22
CA2383292A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
WO1999058683A3 (en) BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
WO1999058684A3 (en) Compounds from moraxella catarrhalis
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO1999064448A3 (en) Moraxella catarrhalis pilq proteins
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
AU6833000A (en) Basb118 polypeptide and polynucleotide from moraxella catarrhalis
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
AU6988700A (en) Basb119 polypeptide and polynucleotide from moraxella catarrhalis
WO2002030960A3 (en) Polypeptide from haemophilus influenza
WO2001019997A3 (en) BASB128 polypeptide and polynucleotide from moxarella catarrhalis
WO2001009332A3 (en) Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
WO1999058682A3 (en) Compounds from moraxella catarrhalis
WO2001009333A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
WO2001009339A3 (en) Moraxella catarrhalis antigen basb117
AU5685500A (en) Basb111 polypeptide and polynucleotide from moraxella catharrhalis
WO1999058685A3 (en) Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
WO2001019862A3 (en) Polypeptides from moraxella (branhamella) catarrhalis
WO2001023416A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2001009172A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2002034772A3 (en) Novel compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000969255

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2383292

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10088125

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000969255

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000969255

Country of ref document: EP